Who owns PALISADE BIO, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PALI from SEC Form 13F filings across 116 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 116 institutions disclosed 177.9M shares of PALISADE BIO, INC. worth $239.5M — about 83.9% of shares outstanding; the largest disclosed holder is Soleus Capital Management, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
116
13F holders
$239.5M
value, 2026 filers
83.9%
of shares outstanding (177.9M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PALI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Soleus Capital Management, L.P. | 15.0M | $20.2M | 0.7% | 7.1% | +14.8% |
| 2 | AMERIPRISE FINANCIAL INC | 14.6M | $19.7M | 0.0% | 6.9% | +31.5% |
| 3 | B Group, Inc. | 11.4M | $15.4M | 9.5% | 5.4% | 0.0% |
| 4 | BlackRock, Inc. | 11.1M | $15.0M | 0.0% | 5.2% | +6.3% |
| 5 | Janus Henderson Group Ltd.NEW | 10.7M | $14.4M | 0.0% | 5% | new |
| 6 | Octagon Capital Advisors LP | 10.3M | $13.9M | 1.8% | 4.8% | 0.0% |
| 7 | PERCEPTIVE ADVISORS LLC | 8.4M | $11.4M | 0.2% | 4% | 0.0% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 7.9M | $10.6M | 0.0% | 3.7% | +357.9% |
| 9 | RA CAPITAL MANAGEMENT, L.P. | 7.1M | $9.6M | 0.1% | 3.4% | 0.0% |
| 10 | FRANKLIN TEMPLETON INC | 6.1M | $7.6M | 0.0% | 2.9% | +4.9% |
| 11 | Point72 Asset Management, L.P. | 5.9M | $7.9M | 0.0% | 2.8% | +11.8% |
| 12 | WELLINGTON MANAGEMENT GROUP LLP | 5.4M | $7.3M | 0.0% | 2.6% | +46.1% |
| 13 | Boxer Capital Management, LLC | 4.8M | $6.5M | 0.6% | 2.3% | 0.0% |
| 14 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.5M | $6.1M | 0.0% | 2.1% | 0.0% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 3.9M | $5.2M | 0.0% | 1.8% | +2.6% |
| 16 | Eversept Partners, LP | 3.5M | $4.7M | 0.3% | 1.6% | -16.9% |
| 17 | FEDERATED HERMES, INC. | 3.1M | $4.2M | 0.0% | 1.5% | 0.0% |
| 18 | Squadron Capital Management LLC | 3.0M | $4.0M | 1.0% | 1.4% | 0.0% |
| 19 | STATE STREET CORP | 2.9M | $4.0M | 0.0% | 1.4% | +18.5% |
| 20 | GOLDMAN SACHS GROUP INC | 2.7M | $3.7M | 0.0% | 1.3% | -24.0% |
| 21 | Vestal Point Capital, LP | 2.5M | $3.4M | 0.1% | 1.2% | 0.0% |
| 22 | SPHERA FUNDS MANAGEMENT LTD. | 2.5M | $3.3M | 0.5% | 1.2% | +9.2% |
| 23 | SILVERARC CAPITAL MANAGEMENT, LLCNEW | 2.3M | $3.2M | 0.4% | 1.1% | new |
| 24 | Aberdeen Group plc | 2.3M | $3.1M | 0.0% | 1.1% | +19.2% |
| 25 | Propel Bio Management, LLC | 2.2M | $3.0M | 1.6% | 1% | -13.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.